eprintid: 10135064
rev_number: 28
eprint_status: archive
userid: 608
dir: disk0/10/13/50/64
datestamp: 2021-10-12 11:47:30
lastmod: 2021-12-03 23:16:20
status_changed: 2021-10-12 11:47:30
type: article
metadata_visibility: show
creators_name: Quartagno, M
creators_name: Morris, TP
creators_name: White, IR
title: Why restricted mean survival time methods are especially useful for non-inferiority trials
ispublished: inpress
divisions: UCL
divisions: B02
divisions: D65
divisions: J38
note: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/)
date: 2021-09-23
date_type: published
publisher: SAGE PUBLICATIONS LTD
official_url: https://doi.org/10.1177/17407745211045124
oa_status: green
full_text_type: pub
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1889034
doi: 10.1177/17407745211045124
lyricists_name: Morris, Timothy
lyricists_name: Quartagno, Matteo
lyricists_name: White, Ian
lyricists_id: TNMOR17
lyricists_id: MQUAR28
lyricists_id: IWWHI35
actors_name: Barczynska, Patrycja
actors_id: PBARC91
actors_role: owner
full_text_status: public
publication: Clinical Trials
article_number: ARTN 174
pages: 3
citation:        Quartagno, M;    Morris, TP;    White, IR;      (2021)    Why restricted mean survival time methods are especially useful for non-inferiority trials.                   Clinical Trials      , Article ARTN 174.  10.1177/17407745211045124 <https://doi.org/10.1177/17407745211045124>.    (In press).    Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10135064/3/2021%20-%20Quartagno%20-%20why%20rmst%20are%20especially%20useful%20for%20ni%20trials%20lte%20-%20clin%20trials.pdf